Bayer’s strong first quarter performance was mainly driven by its pharmaceuticals division, even as its crop-science branch lagged.
Trending
- US sank Iranian warship, Pentagon announces in press briefing
- Iran attacks on Gulf oil and gas sites trigger energy fears
- ‘Hamnet’ | Anatomy of a Scene
- Asia stock markets slump and oil rises on fears Iran war may drag on
- AI could be giving US lethal edge in Iran war – but there are dangers | Science, Climate & Tech News
- Can a robot recruiter really spot a good carer?
- Midden in de nacht wakker: expert geeft tips om snel weer in slaap te vallen
- Pregnant women's brains shed grey matter to prime them for motherhood, study suggests
